Table 4.
Treatment | Body weight, mm | LV weight, g | LV/BW × 103 | Lung wet/dry weight ratio | LV/TL × 103, g/mm |
---|---|---|---|---|---|
Sham + Ad.βgal | 578 ± 34 | 1.09 ± 0.14 | 1.9 ± 0.1 | 3.7 ± 0.5 | 26.4 ± 5 |
Failing + Ad.βgal | 596 ± 41 | 1.82 ± 0.22* | 3.1 ± 0.1* | 5.6 ± 0.7* | 44.3 ± 6* |
Sham + SERCA2a | 559 ± 44 | 1.14 ± 0.15 | 2.1 ± 0.1 | 3.6 ± 0.4 | 28.5 ± 4 |
Failing + SERCA2a | 611 ± 51 | 1.85 ± 0.17*† | 3.0 ± 0.2*† | 4.7 ± 0.5*† | 45.1 ± 5*† |
LV, left ventricle; *, P < 0.05 compared to Sham + Ad.βgal; †, P < 0.05 compared to Sham + Ad.SERCA2a.